Autoregulation of Thromboinflammation on Biomaterial Surfaces by a Multicomponent Therapeutic Coating

Overview

Journal Biomaterials

Specialty Biomedical Engineering

Date 2012 Nov 10

PMID 23137394

Citations 13

Authors

Per H Nilsson

Kristina N Ekdahl

Peetra U Magnusson

Hongchang Qu

Hiroo Iwata

Daniel Ricklin

Jaan Hong

John D Lambris

Bo Nilsson

Yuji Teramura

Affiliations

Soon will be listed here.

Abstract

Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact. We have created a surface which is auto-protective to human innate immunity by combining three fundamentally different strategies, all developed by us previously, which have been shown to induce substantial, but incomplete hemocompatibility when used separately. In summary, we have conjugated a factor H-binding peptide; and an ADP-degrading enzyme; using a PEG linker on both material and cellular surfaces. When exposed to human whole blood, factor H was specifically recruited to the modified surfaces and inhibited complement attack. In addition, activation of platelets and coagulation was efficiently attenuated, by degrading ADP. Thus, by inhibiting thromboinflammation using a multicomponent approach, we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation.

Citing Articles

Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop.

Ekdahl K, Fromell K, Mannes M, Grinnemo K, Huber-Lang M, Teramura Y Immunol Rev. 2022; 313(1):91-103.

PMID: 36258635 PMC: 10092679. DOI: 10.1111/imr.13148.

The Proteome of Antibody-Mediated Rejection: From Glomerulitis to Transplant Glomerulopathy.

Chauveau B, Raymond A, Di Tommaso S, Visentin J, Vermorel A, Dugot-Senant N Biomedicines. 2022; 10(3).

PMID: 35327371 PMC: 8945687. DOI: 10.3390/biomedicines10030569.

Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.

Strohbach A, Busch R Int J Mol Sci. 2021; 22(21).

PMID: 34768821 PMC: 8583792. DOI: 10.3390/ijms222111390.

The renaissance of complement therapeutics.

Ricklin D, Mastellos D, Reis E, Lambris J Nat Rev Nephrol. 2017; 14(1):26-47.

PMID: 29199277 PMC: 5805379. DOI: 10.1038/nrneph.2017.156.

Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Ricklin D, Reis E, Mastellos D, Gros P, Lambris J Immunol Rev. 2016; 274(1):33-58.

PMID: 27782325 PMC: 5427221. DOI: 10.1111/imr.12500.

References

Markiewski M, Nilsson B, Nilsson Ekdahl K, Mollnes T, Lambris J . Complement and coagulation: strangers or partners in crime?. Trends Immunol. 2007; 28(4):184-92. DOI: 10.1016/j.it.2007.02.006. View

Platts-Mills T, Ishizaka K . Activation of the alternate pathway of human complements by rabbit cells. J Immunol. 1974; 113(1):348-58. View

Nilsson P, Engberg A, Back J, Faxalv L, Lindahl T, Nilsson B . The creation of an antithrombotic surface by apyrase immobilization. Biomaterials. 2010; 31(16):4484-91. PMC: 2852686. DOI: 10.1016/j.biomaterials.2010.02.036. View

Eltzschig H, Thompson L, Karhausen J, Cotta R, Ibla J, Robson S . Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood. 2004; 104(13):3986-92. DOI: 10.1182/blood-2004-06-2066. View

Cattaneo M, Gachet C . ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol. 1999; 19(10):2281-5. DOI: 10.1161/01.atv.19.10.2281. View

Engberg A, Sandholm K, Bexborn F, Persson J, Nilsson B, Lindahl G . Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. Biomaterials. 2009; 30(13):2653-9. PMC: 2700260. DOI: 10.1016/j.biomaterials.2009.01.001. View

Teramura Y, Kaneda Y, Iwata H . Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials. 2007; 28(32):4818-25. DOI: 10.1016/j.biomaterials.2007.07.050. View

Andersson J, Bexborn F, Klinth J, Nilsson B, Nilsson Ekdahl K . Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. J Biomed Mater Res A. 2005; 76(1):25-34. DOI: 10.1002/jbm.a.30377. View

Teramura Y, Iwata H . Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation. 2011; 91(3):271-8. DOI: 10.1097/tp.0b013e3182034fa4. View

10.

Andersson J, Nilsson Ekdahl K, Lambris J, Nilsson B . Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials. 2004; 26(13):1477-85. DOI: 10.1016/j.biomaterials.2004.05.011. View

11.

Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp J . Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol. 2010; 8(6):393-9. DOI: 10.1038/nrmicro2366. View

12.

Marcus A, Broekman M, Drosopoulos J, Islam N, Alyonycheva T, Safier L . The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest. 1997; 99(6):1351-60. PMC: 507951. DOI: 10.1172/JCI119294. View

13.

Van Linden A, Eltzschig H . Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26. Expert Opin Biol Ther. 2007; 7(9):1437-47. DOI: 10.1517/14712598.7.9.1437. View

14.

Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R . Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002; 360(9350):2039-45. DOI: 10.1016/s0140-6736(02)12020-4. View

15.

Reutershan J, Cagnina R, Chang D, Linden J, Ley K . Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol. 2007; 179(2):1254-63. DOI: 10.4049/jimmunol.179.2.1254. View

16.

Tengvall P, Askendal A, Lundstrom I . Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon. J Biomed Mater Res. 1997; 35(1):81-92. DOI: 10.1002/(sici)1097-4636(199704)35:1<81::aid-jbm8>3.0.co;2-i. View

17.

Wu Y, Qu H, Sfyroera G, Tzekou A, Kay B, Nilsson B . Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J Immunol. 2011; 186(7):4269-77. PMC: 3123137. DOI: 10.4049/jimmunol.1003802. View

18.

Diepenhorst G, van Gulik T, Hack C . Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg. 2009; 249(6):889-99. DOI: 10.1097/SLA.0b013e3181a38f45. View

19.

Andersson J, Larsson R, Richter R, Ekdahl K, Nilsson B . Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. Biomaterials. 2001; 22(17):2435-43. DOI: 10.1016/s0142-9612(00)00431-2. View

20.

Andersson J, Nilsson Ekdahl K, Larsson R, Nilsson U, Nilsson B . C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol. 2002; 168(11):5786-91. DOI: 10.4049/jimmunol.168.11.5786. View